RUBIN’S REFLECTIONS

Follow on Twitter @IBDMD

Message to Dr. Rubin’s Patients Related to COVID-19 Boosters

Aug 13, 2021

Dear Friends and Patients, I hope this message finds you well. Please excuse the group nature of this message, but I did want to reach out with the latest update about COVID-19, and vaccinations. If you want to skip right to the booster info, scroll down to #5 below....

Tweetorial to Provide Updates on COVID-19 for Patients with IBD

Jul 30, 2021

View Twitter Thread To watch me deliver the full lecture and view the presentation, click here. I recently gave a lecture about COVID-19 and vaccination with specific information for patients with IBD. This lecture was recorded on July 21st, before the CDC issued...

Tweetorial to Clarify the NYT Article From 15 April and Further Explain/Clarify the UK CLARITY IBD Study

Apr 18, 2021

Tweetorial to Clarify the NYT Article From 15 April and Further Explain/Clarify the UK CLARITY IBD Study David T. Rubin View Twitter Thread I've previously commented about the CLARITY IBD Study (Kennedy, et al). paper in this forum, but it bears repeating and further...

SARS Vaccine and IBD Tweetorial Summary from December 1

Dec 5, 2020

SARS Vaccine and IBD Tweetorial Summary from December 1 David T. Rubin View Twitter Thread Here are my thoughts and a few updates about SARS-CoV-2 vaccines, and also about important implications for our IBD patients. Development of multiple SARS-CoV-2 vaccines in the...

Approach to Management and Interpretation of Testing Results in Patients with IBD, with Particular Attention to Restarting Therapy

Apr 21, 2020

By David T. Rubin, MD, Professor of Medicine, University of Chicago Medicine As testing for SARS-CoV-2 is expanded and serologic antibody testing becomes available, we are faced with a number of different clinical scenarios. I have outlined the different situations...

Three waves of Illness from the COVID-19 Pandemic

Apr 1, 2020

By David T. Rubin, MD, Professor of Medicine, University of Chicago Medicine I've been thinking about what comes next, and how can we get ahead of this, and propose the following for consideration. I believe that there will be three waves of illness from the...

Long-Duration Vancomycin Linked to Lower Rates of C. diff Recurrence in IBD

by dtrubin | December 6, 2019 | In the Press | 0 Comments

Pritzker medical student Donald Lei's manuscript was accepted to the American Journal of Gastroenterology. Reuters Health Information reported on the study with comments by Dr. Rubin. "Our study did in fact demonstrate significantly reduced rates of recurrence...

Dr. Rubin featured on CME Outfitters “COVID-19 + IBD” Episode

by dtrubin | May 22, 2020 | In the Press | 0 Comments

The data on COVID-19 is changing rapidly and can be overwhelming. Having been on the frontlines of the pandemic, Dr. David T. Rubin, Dr. Sushila Dalal, and Dr. Miguel Regueiro break down the latest information and best practices for managing patients with IBD and...

Dr. David T. Rubin Reflects on How to Avoid the Next Pandemic with WGN’s Steve Dale

by David Rubin | January 18, 2022 | In the Press | 0 Comments

Click here to listen to the full interview.

Dr. David T. Rubin Summarizes His Presentation from Digestive Diseases Week on Advancing Therapies and the Field of IBD

by David Rubin | June 7, 2023 | In the Press | 0 Comments

Click here to listen to Dr. Rubin discuss the importance of head-to-head and comparative trials, combination therapies, optimization with timing, escalation and de-escalation, and how we should approach new therapies.

How IBD Can Affect Patients’ Career and School Choices

by dtrubin | December 3, 2019 | QoL, Rubin's Reflections | 0 Comments

IBD, perhaps more than other chronic illnesses, can have a definite impact on a patient’s career choices and school performance. Therefore, I have definitely seen patients make decisions that are affected by their IBD. However, more often, I’ve seen patients overcome...

Dr. David T. Rubin Hosts Pearls from the Pros on IBD Management

by David Rubin | March 1, 2022 | In the Press | 0 Comments

Dr. Rubin hosted four episodes of MedEd Talks Gastroenterology's Pearls from the Pros on IBD Management, featuring several colleagues to discuss best practices in using different classes of IBD therapies. Dr. Rubin spoke with Dr. Bruce Sands, Gastroenterologist and...

“Monitor Histologically Normalized UC for Relapse” on MedPage Today

by dtrubin | June 27, 2019 | histology, In the Press, normalization, UC | 0 Comments

"These patients require ongoing monitoring and follow-up," the study's first author, Amanda M. Israel, MD, also of the University of Chicago Medicine, told MedPage Today. Our graduating Advanced IBD Fellow, Amanda Israel, was published her findings on the “Follow-Up...

IBD Drive Time Podcast: Ethical Issues in Clinical Trials

by David Rubin | October 19, 2023 | In the Press | 0 Comments

Take a listen to the third episode of a four-part series wherein Professor Rubin guest-hosts the Gastroenterology Learning Network's IBD Drive Time and discusses the ethics of clinical trials in IBD, as well as challenges to recruitment, alongside Professor Severine...

Doctor Podcasts: Crohn’s Disease, Ulcerative Colitis, Inflammatory Bowel Disease; latest updates & great treatments.

by zfine | January 9, 2026 | In the Press | 0 Comments

Episode 132 of The DoctorPodcasts Show features Dr. David Rubin discussing Crohn’s disease, ulcerative colitis, and inflammatory bowel disease, including the latest advances and treatment options. https://www.youtube.com/watch?v=tSEA4yuE5FU

‘We’ve Moved the Needle Quite Far’ in Management of Crohn Disease

by dtrubin | November 27, 2018 | CD, In the Press, therapies | 0 Comments

Dr. Rubin discusses how the management of Crohn disease has changed over time, the importance of understanding the disease for proper management, and common mistakes in treatment that remain.